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The concept of developmental origins of health and 
disease is predicated upon the assumption that environ­
mental factors acting early in life (usually in fetal life) 
have profound effects on vulnerability to disease later in 
life, often in adulthood. The range of experimental, 
clinical and epidemiological data linking conditions in 
early life to later health is now overwhelming [1]. Initially, 
the focus was on a small fraction of children ­those who 
were born small ­ but it is now clear that the environment 
impacts on the development of every child [2]. Obser­
vations and experimental approaches have generally 
considered nutritional changes or, classically, alterations 
in glucocorticosteroid exposure, reflecting the critical 
maturational events linked to such events. Indeed, the 
placenta is in a critical position to cause or modify such 
challenges by altering nutritional transport functions or 
the pattern and nature of endocrine signals impacting the 
fetus. Nor does the story end at birth, because epigenetic 
development can be influenced by how the infant is fed, 
and perhaps how its gut is colonized with commensal 
bacteria.
Yet there has been considerable resistance to these 
ideas. Medicine is replete with reductionist biomedical 
thinking and this has, in some ways, limited not only our 
understanding but also our ability to address the 
challenge of some contemporary health problems. 
Nowhere is this clearer than in the outcomes of genome­
wide association studies where, despite substantial 
invest ment, only a relatively small proportion of risk of 
common non­communicable diseases (NCDs) ­ such as 
cardiovascular disease and diabetes ­ is explained [3]. The 
economic and humanitarian costs of NCDs are enormous 
in both the developed and the developing world, and 
indeed they may destabilize the economies of low­
income countries where recent data show that risk 
markers for these diseases become evident early in the 
process of socioeconomic improvement, and well below 
the level of affluence associated with their appearance in 
developed societies. From research laboratory to public 
health department, the focus on the processes that 
influence risk of NCD has been largely on genetic or 
adult lifestyle factors, to the exclusion of a third, critical 
component, namely development. We now recognize 
that incorporating an understanding of developmental 
plasticity and intergenerational influences, operating 
directly or indirectly through epigenetic mechanisms and 
potentially over more than one generation, is essential to 
understanding variation in the individual risk of NCD, 
for example, in an obesogenic environment [4].
Epigenetic processes provide a biological mechanism to 
explain how environmental influences can affect the 
pheno typic variation of a generation, or several genera­
tions, including their susceptibility to NCDs [4]. These 
epigenetic processes were formerly thought to be 
primarily involved in gene dosage regulation via parental 
imprinting and X chromosome inactivation, and in 
regulating cell lineage differentiation. But environmental 
influences during development, such as maternal diet or 
endocrine status, can affect offspring phenotype via 
epigenetic effects on a range of non­imprinted genes, for 
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example, the glucocorticoid receptor [5] and nuclear 
receptors such as the peroxisome proliferator­activated 
receptors [6]. These processes can operate from before 
conception into early postnatal life and can affect 
neuroendocrine and endocrine function, fat and muscle 
development, and metabolic control processes such as 
mitochondrial function [4].
Phenotypic outcomes with long­term consequences 
thus involve the interplay between genetic, develop­
mental and environmental influences. It is impossible to 
pull them apart. In contrast to the fatalism of a 
deterministic view, this new synthesis gives room for 
optimism. The epigenetic state has been shown to be 
reversible, with persistent effects from transient inter­
ventions during a critical developmental window in animal 
models [6,7] suggesting the potential for early intervention. 
In cancer biology, epigenetic biomarkers and drug 
targeting are burgeoning fields but, as yet, little attention 
has been given to the potential for epigenetic 
measurements in early­life interventions to reduce the 
incidence of NCDs. The ways adults interact with the 
environment, food preference, appetite control, mood 
and exercise capacity, for example, have been shown 
experimentally to be influenced by development [2,6]. 
Perhaps then the efficacy of the very interventions that 
form the mainstay of metabolic and cardiovascular 
disease prevention in adults is affected by early­life 
exposures.
If we adopt a developmental perspective, the question 
arises ­ what new initiatives might be taken? In adolescent 
pregnancies the conflict between allocation of nutrients to 
the woman or to her fetus is usually resolved in favor of the 
mother. This makes evolutionary sense but the 
epigenetically induced constraint puts the offspring at 
greater risk of later disease [2]. Thus, educational and 
social initiatives aimed at delaying the age of first 
pregnancy until four years after menarche, to allow 
maternal somatic and particularly pelvic growth to be 
completed, would not only empower women in controlling 
their lives but also promote the health of the next 
generation. The cultural and political issues preventing 
implementation of such a strategy need to be confronted.
Similar considerations apply to maternal diet and body 
composition at conception. Animal studies demonstrate 
long­term effects of both excessive and deficient nutrition 
in this period on the offspring, and human data reveal 
effects on birth outcomes. Studies in the UK show that 
many women do not eat prudently around conception 
[8], and only a minority of women becoming pregnant, 
whether planned or not, adhere to guidelines about a 
healthy diet and lifestyle [9]. Moreover, gestational 
obesity and diabetes, themselves with developmental 
origins, both leave lasting effects on the offspring of the 
next generation, and so the cycle of risk is perpetuated.
Education and other ways to address these problems 
need to be explored. Nutrition and workload in preg­
nancy need greater attention, and not only in the 
developing world. In Japan, birth weight has been falling 
in recent years and this is attributed to inadequate weight 
gain in pregnancy, sometimes following ill­conceived 
medical advice. Smoking, drug and alcohol abuse, HIV­
AIDS and malaria still complicate far too many 
pregnancies. Human development is far from complete 
at birth, and recent data confirm the importance of 
exclusive breastfeeding for up to four to six months in 
promoting optimal growth, resistance to infection, 
cardiovascular health and neurocognitive development. 
Yet breastfeeding rates are low even in developed 
countries such as the UK, and the number of women 
reaching the goal is far too low ­ support and encourage­
ment for them are needed urgently.
None of these solutions seems sophisticated, although 
it may have taken the recent insights into underlying 
developmental epigenetic mechanisms to emphasize 
them. But, when viewed in terms of their potential 
impact, especially in developing societies and in lower 
socioeconomic groups in developed countries, it is clear 
that their importance has been underestimated. Public 
health decision makers should reflect on this and 
consider possible actions [10].
 
We fear that eradicating 
the inflexibility of past biomedical concepts about 
development, in favor of a softer integrative synthesis, 
will be seen as too difficult ­ we may continue to find it 
easier to think deterministically about chronic disease 
and then to be surprised when, perhaps because they are 
made too late, interventions turn out to be relatively 
ineffective. Adopting a developmental perspective may 
not influence our approach to minimizing risk of NCDs 
in today’s adults. But surely, when we see potential risk 
from that angle, we should resolve to use our develop­
mental perspective to devise interventions in time to help 
the next generation.
Abbreviations
NCD, non-communicable disease.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Each author has contributed equally to the final manuscript.
Author details
1Liggins Institute, The University of Auckland, Private Bag 92019, Auckland 
1142, New Zealand 
2National Research Centre for Growth and Development, The University of 
Auckland, Private Bag 92019, Auckland 1142, New Zealand 
3Centre for Developmental Origins of Health and Disease, University of 
Southampton, Southampton SO16 5YA, UK 
4UQ Centre for Clinical Research, Building 71/198, Royal Brisbane and Women’s 
Hospital Campus, Brisbane, Queensland 4072, Australia
Published: 24 February 2010
Gluckman et al. Genome Medicine 2010, 2:14 
http://genomemedicine.com/content/2/2/14
Page 2 of 3
References
1. Newnham JP, Ross MG (Eds): Early Life Origins of Human Health and Disease. 
Basel: Karger; 2009.
2. Gluckman PD, Hanson MA, Beedle AS: Early life events and their 
consequences for later disease: a life history and evolutionary perspective. 
Am J Hum Biol 2007, 19:1-19.
3. Maher B: Personal genomes: the case of the missing heritability. Nature 
2008, 456:18-21.
4. Gluckman PD, Hanson MA, Cooper C, Thornburg KL: Effect of in utero and 
early-life conditions on adult health and disease. N Engl J Med 2008, 
359:61-73.
5. Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR, 
Dymov S, Szyf M, Meaney MJ: Epigenetic programming by maternal 
behavior. Nat Neurosci 2004, 7:847-854.
6. Gluckman PD, Lillycrop KA, Vickers MH, Pleasants AB, Phillips ES, Beedle AS, 
Burdge GC, Hanson MA: Metabolic plasticity during mammalian 
development is directionally dependent on early nutritional status. Proc 
Natl Acad Sci U S A 2007, 104:12796-12800.
7. Park JH, Stoffers DA, Nicholls RD, Simmons RA: Development of type 2 
diabetes following intrauterine growth retardation in rats is associated 
with progressive epigenetic silencing of Pdx1. J Clin Invest 2008, 
118:2316-2324.
8. Robinson SM, Crozier SR, Borland SE, Hammond J, Barker DJP, Inskip HM: 
Impact of educational attainment on the quality of young women’s diets. 
Eur J Clin Nutr 2004, 58:1174-1180.
9. Inskip HM, Crozier SR, Godfrey KM, Borland SE, Cooper C, Robinson SM: 
Women’s compliance with nutrition and lifestyle recommendations 
before pregnancy: general population cohort study. BMJ 2009, 338:b481.
10. World Health Organization. Promoting Optimal Fetal Development: Report of a 
Technical Consultation. Geneva: WHO; 2006.
Gluckman et al. Genome Medicine 2010, 2:14 
http://genomemedicine.com/content/2/2/14
doi:10.1186/gm135
Cite this article as: Gluckman PD, et al.: Developmental origins of health 
and disease: reducing the burden of chronic disease in the next generation. 
Genome Medicine 2010, 2:14.
Page 3 of 3
